- Global Locations -


Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705


Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531


Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates


Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Bronchitis Treatment Market Overview

The global Bronchitis Treatment Market was valued at around US$ 5.5 Bn at the end of 2021. The market is projected to register a 4.1% CAGR and top a valuation of US$ 8.5 Bn by 2032.

“Rising geriatric population worldwide and increasing patient pool with bronchitis and other respiratory disorders are variables expected to set the tone of bronchitis treatment market.”

A medical condition called bronchitis causes the bronchial tubes to become inflamed, which results in coughing, usually with mucus. Dyspnea (shortness of breath), a cough that produces mucus, wheezing while breathing, and chest pain are all signs of bronchitis.

Bronchitis risk factors include viral or bacterial infections, ;smoking, gastric reflux, and ;exposure to irritants at work such as ;dust, ;pollution, ;and others. Pneumonia is one of the most frequent side effects of bronchitis and often happens when the infection progresses deeper into the lungs. Thus, the fluid in the lungs' air sacs fills up due to this illness.



Bronchitis Treatment Market Value in 2021

US$ 5.5 Bn

Bronchitis Treatment Market Value in 2032

US$ 8.5 Bn

Bronchitis Treatment Market CAGR (2022-2032)


Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Major Drivers Boosting the Demand for Bronchitis Treatment Market?

The aging ;population with a higher incidence of bronchitis, higher levels of toxic chemicals and pollutants, and exposure to dust in the workplace or environment are major factors propelling the growth of the ;market. Additionally, people with a history of bronchitis in their families may have it more frequently.

For instance, one of the main factors fueling the expansion of the market for bronchitis treatments is the rising prevalence of smoking. In the US, over 32,000 ;million people used cigarettes in 2020, according to the CDC.

Significant ;factors that can have a major impact on the revenue growth of the global bronchitis treatment market include government-led initiatives to increase treatment awareness and market penetration of the key players ;in developing economies. The treatment of COPD has advanced, including the use of small-cell therapy and combination medications. Additionally, nonpharmacological treatments have become more popular over time.

Which Region Shows Strong Growth Potential in the Bronchitis Treatment Market?

The bronchitis treatment market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

A huge chunk of the global market belongs to North America because of the region's developed healthcare infrastructure and the ;population's awareness of health issues.

Apart from North America, the European market is also anticipated to grow at a rapid pace, due to the rising prevalence of chronic bronchitis and increasing healthcare expenditure by European Commissions.

Furthermore, the Asia Pacific region is also expected to uplift the revenue of the bronchitis treatment market due to the high presence of pollutants in numerous developing economies in Asia which has led to extensive R&D activities in the region to reduce the morbidity of chronic bronchitis.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Who are the Key Manufacturers in the Bronchitis Treatment Market?

Melinta Therapeutics, AstraZeneca, Pfizer Inc., Abbot, GlaxoSmithKline Plc., Cadila Healthcare Limited., Sanofi SA., Novartis, Glenmark, Cipla Inc, Dr. Reddy's Laboratories Ltd., Boehringer Ingelheim Pharmaceuticals, Inc.

Scope of Report

Report Attributes


Growth Rate

CAGR of 4.1% 2022-2032

Base Year for Estimation


Historical Data


Forecast Period


Qualitative Units

Revenue in USD Billion, and CAGR from 2022-2032

Report Coverage

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends

Segment Covered

  • Type
  • Treatment
  • Drug Class
  • Distribution Channel
  • Region

Region Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC
  • South Africa
  • Israel

Key Players

  • Melinta Therapeutics
  • AstraZeneca
  • Pfizer Inc.
  • Abbot
  • GlaxoSmithKline Plc.
  • Cadila Healthcare Limited.
  • Sanofi SA.
  • Novartis
  • Glenmark
  • Cipla Inc
  • Dr. Reddy's Laboratories Ltd.
  • Boehringer Ingelheim Pharmaceuticals, Inc.


Available Upon Request

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Covered in the Bronchitis Treatment Industry Survey

By Type:

  • Chronic Bronchitis
  • Acute Bronchitis

By Treatment:

  • Drugs
  • Oxygen Therapy

By Drug Class:

  • Antibiotics
  • Anti-inflammatory Drugs
  • Bronchodilator
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • The Middle East and Africa (MEA)

Frequently Asked Questions

What is the Growth Outlook for Bronchitis Treatment Market?

The market is likely to register a CAGR of 4.1% through 2032.

What is the Current Valuation of the Bronchitis Treatment Market?

The market is currently valued at US$ 3.83 Mn in 2022.

How is the Future of the Bronchitis Treatment Market?

The market is likely to grow to a valuation of US$ 6.06 Mn by 2032.

Which is the Leading Region in the Market?

North America is likely to be a leading market during the forecast period.



Dysmenorrhea Treatment Market

Published : August 2023


Aflatoxicosis Treatment Market

Published : July 2023


Scabies Treatment Market

Published : November 2022


Allergy Treatment Market

Published : November 2022

Explore Healthcare Insights

View Reports

Bronchitis Treatment Market

Schedule a Call